Incyte to Report Third Quarter Financial Results

WILMINGTON, Del.--()--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its third quarter 2015 financial results conference call and webcast for 10:00 a.m. ET on Tuesday, November 3, 2015.

The schedule for the press release and conference call/webcast is as follows:

         

• Q3 2015 Press Release:

November 3, 2015 at 7:00 a.m. ET

• Q3 2015 Conference Call:

November 3, 2015 at 10:00 a.m. ET

• Domestic Dial-In Number:

877-407-9221

• International Dial-In Number:

201-689-8597

• Conference ID Number:

13622010
 

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and the dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 13622010.

The live webcast with slides can be accessed at www.incyte.com under Investor Relations, Events and Webcasts and will be available for replay for 30 days.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics, primarily for oncology. For additional information on Incyte, please visit the Company's web site at www.incyte.com.

Contacts

Incyte Corporation
Investors
Michael Booth, DPhil, +1 302-498-5914
mbooth@incyte.com
or
Media
Catalina Loveman, +1 302-498-6171
cloveman@incyte.com

Contacts

Incyte Corporation
Investors
Michael Booth, DPhil, +1 302-498-5914
mbooth@incyte.com
or
Media
Catalina Loveman, +1 302-498-6171
cloveman@incyte.com